482 related articles for article (PubMed ID: 7974202)
1. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
[TBL] [Abstract][Full Text] [Related]
2. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
3. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
4. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
6. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
Lawler CP; Gilmore JH; Watts VJ; Walker QD; Southerland SB; Cook LL; Mathis CA; Mailman RB
Synapse; 1995 Dec; 21(4):299-311. PubMed ID: 8869160
[TBL] [Abstract][Full Text] [Related]
7. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
Jin S; Johansson B; Fredholm BB
J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil on the release of different neurotransmitters.
Sitges M; Reyes A
J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
[TBL] [Abstract][Full Text] [Related]
10. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
[TBL] [Abstract][Full Text] [Related]
11. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
Wersinger C; Chen J; Sidhu A
Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
[TBL] [Abstract][Full Text] [Related]
12. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
13. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
14. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
15. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
16. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
17. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
[TBL] [Abstract][Full Text] [Related]
18. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
19. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
20. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
